Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Anim Hosp Assoc ; 43(1): 61-4, 2007.
Article in English | MEDLINE | ID: mdl-17209087

ABSTRACT

A 10-year-old, castrated male, domestic longhaired cat with a history of urinary tract disease and perineal urethrostomy was presented for evaluation of persistent urinary tract inflammation. Prior to referral, diphtheroid organisms had been cultured from a urine sample obtained by cystocentesis, and they were interpreted as sample contamination. Subsequent urine culture and gene sequencing identified Corynebacterium jeikeium, which was resistant to antibiotics and appeared to be the cause of the urinary tract infection.


Subject(s)
Anti-Infective Agents/pharmacology , Cat Diseases/drug therapy , Corynebacterium Infections/veterinary , Corynebacterium/isolation & purification , Urinary Tract Infections/veterinary , Animals , Anti-Infective Agents/administration & dosage , Bacteriuria/microbiology , Cat Diseases/microbiology , Cats , Corynebacterium/drug effects , Corynebacterium/genetics , Corynebacterium Infections/drug therapy , Corynebacterium Infections/microbiology , Drug Resistance, Multiple, Bacterial , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Male , Microbial Sensitivity Tests/veterinary , RNA, Ribosomal, 16S/genetics , Treatment Outcome , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology
2.
Stroke ; 33(11): 2704-10, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12411665

ABSTRACT

BACKGROUND AND PURPOSE: Production of NO by endothelial NO synthase (eNOS) plays a protective role in cerebral ischemia. We studied the effects of transient focal ischemia on eNOS expression. METHODS: Wistar rats (n=72) underwent reversible filament occlusion of the right middle cerebral artery for 75 minutes. After 6, 24, 72, or 168 hours of reperfusion, brains were removed and coronal sections cut for eNOS immunohistochemistry, eNOS-alkaline phosphatase costaining, and hematoxylin-eosin staining. Samples for eNOS immunoblots were taken from corresponding striatum and overlying parietal cortex bilaterally. RESULTS: eNOS protein occurred in virtually all blood vessels and was consistently increased in microvessels in the ischemic striatum after 24 to 168 hours of reperfusion but not at 6 hours. eNOS upregulation in the parietal cortex was only present in animals with evidence of cortical infarcts documented on adjacent HE-stained sections. Costaining of endogenous alkaline phosphatase and eNOS demonstrated eNOS expression in all segments of cerebral microvessels. Quantitative analysis of eNOS immunostaining and immunoblots showed no attenuated increase in animals that were treated with indomethacin (5 mg/kg IP), NS398 (20 mg/kg IP), or L-arginine-methyl ester (10 mg/kg IP). In contrast to eNOS, levels of brain NOS did not increase after ischemia. CONCLUSION: eNOS protein is upregulated in pre- and postcapillary microvessels and upregulation appears slower after transient compared with permanent ischemia. Cyclooxygenase and NOS products do not play a major role in postischemic eNOS induction.


Subject(s)
Blood Vessels/enzymology , Brain/enzymology , Cerebrovascular Circulation , Ischemic Attack, Transient/enzymology , Nitric Oxide Synthase/metabolism , Animals , Blood Vessels/drug effects , Blood Vessels/pathology , Blotting, Western , Brain/blood supply , Brain/pathology , Corpus Striatum/blood supply , Corpus Striatum/enzymology , Corpus Striatum/pathology , Enzyme Inhibitors/pharmacology , Immunoblotting , Immunohistochemistry , Infarction, Middle Cerebral Artery/complications , Infarction, Middle Cerebral Artery/enzymology , Infarction, Middle Cerebral Artery/pathology , Ischemic Attack, Transient/etiology , Ischemic Attack, Transient/pathology , Male , Microcirculation/drug effects , Microcirculation/enzymology , Microcirculation/pathology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type I , Nitric Oxide Synthase Type III , Parietal Lobe/blood supply , Parietal Lobe/enzymology , Parietal Lobe/pathology , Rats , Rats, Wistar , Up-Regulation
3.
Am J Physiol Regul Integr Comp Physiol ; 283(6): R1362-7, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12429559

ABSTRACT

We determined whether cerebral arteriolar dilation to N-methyl-d-aspartate (NMDA), a response dependent on stimulation of cortical neurons and inhibited by anoxic stress, would be preserved by hypothermia during and following ischemia. Pial arteriolar diameters in anesthetized piglets were determined via intravital microscopy. Arteriolar responses to NMDA (10, 50, and 100 micromol/l) were measured before and 1 h after 10 min of global ischemia. Piglets were exposed to either total body or selective brain cooling (33-34 degrees C). Arteriolar dilation to lower doses or to 100 micromol/l NMDA was not affected by hypothermia alone (51 +/- 3 vs. 46 +/- 7%, normothermia vs. hypothermia; n = 7) in nonischemic animals. However, arteriolar responses to 100 micromol/l NMDA were clearly attenuated after ischemia despite body cooling during ischemia (53 +/- 3 vs. 32 +/- 6%; n = 8), hypothermia during ischemia and early reperfusion (49 +/- 10 vs. 20 +/- 3%; n = 8), or selective brain cooling (48 +/- 5 vs. 20 +/- 5%; n = 10). In contrast, pretreatment with indomethacin resulted in complete preservation of NMDA-induced vasodilation after ischemia. Thus, hypothermia fails to protect against neuronal dysfunction during ischemia.


Subject(s)
Brain Ischemia/physiopathology , Brain/blood supply , Brain/physiology , Hypothermia, Induced , Swine/physiology , Animals , Arterioles/drug effects , Arterioles/physiology , Brain/drug effects , Cerebral Arteries/drug effects , Cerebral Arteries/physiology , Female , Indomethacin/pharmacology , Male , N-Methylaspartate/pharmacology , Vasodilation/drug effects
4.
Hypertension ; 40(1): 78-82, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12105142

ABSTRACT

Although insulin-mediated vasodilation is impaired in insulin resistance, the mechanisms of this are unknown. We investigated factors mediating vasoactive responses to insulin in control and insulin-resistant rats. Responses to insulin in small mesenteric arteries from control and insulin-resistant rats were investigated after blocking endothelin-A receptors, cyclooxygenase, nitric oxide synthase, and potassium channels. In addition, insulin's effect on prostacyclin production in small mesenteric blood vessels was assessed by enzyme immunoassay. Insulin induced a concentration-dependent vasodilation in control arteries that was absent in arteries from insulin-resistant rats. However, in the presence of BQ610, an endothelin-A receptor antagonist, the response to insulin was normalized in insulin-resistant arteries. In control arteries, insulin-induced vasodilation was completely inhibited by indomethacin, meclofenamate, glibenclamide, or potassium chloride. In contrast, neither n-nitro-L-arginine nor the combination of charybdotoxin and apamin altered vasodilation to insulin. In insulin-resistant arteries in the presence of BQ610, vasodilation was also inhibited by indomethacin, glibenclamide, and potassium chloride. Insulin increased prostacyclin production in small mesenteric blood vessels from both groups of rats to a similar degree. Insulin-induced vasodilation in small rat mesenteric arteries is mediated through prostacyclin- and ATP-dependent potassium channels. However, insulin-resistant arteries do not vasodilate to insulin unless endothelin-A receptors are blocked. Thus, impaired relaxation to insulin in insulin-resistant rats is due to enhanced vasoconstriction by endothelin, which offsets a normal vasodilatory response to insulin.


Subject(s)
Endothelins/metabolism , Insulin Resistance/physiology , Insulin/pharmacology , Vasodilation/drug effects , 6-Ketoprostaglandin F1 alpha/metabolism , Animals , Dose-Response Relationship, Drug , Endothelin Receptor Antagonists , Glyburide/pharmacology , In Vitro Techniques , Indomethacin/pharmacology , Male , Mesenteric Artery, Superior/drug effects , Mesenteric Artery, Superior/physiology , Oligopeptides/pharmacology , Potassium Chloride/pharmacology , Rats , Rats, Sprague-Dawley , Receptor, Endothelin A
5.
Am J Physiol Heart Circ Physiol ; 283(1): H406-11, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12063315

ABSTRACT

We investigated the mechanism of EDHF-mediated dilation to bradykinin (BK) in piglet pial arteries. Topically applied BK (3 micromol/l) induced vasodilation (62 +/- 12%) after the administration of N(omega)-nitro-L-arginine methyl ester (L-NAME) and indomethacin, which was inhibited by endothelial impairment or by the BK(2) receptor antagonist HOE-140 (0.3 micromol/l). Western blotting showed the presence of BK(2) receptors in brain cortex and pial vascular tissue samples. The cytochrome P-450 antagonist miconazole (20 micromol/l) and the lipoxygenase inhibitors baicalein (10 micromol/l) and cinnamyl-3,4-dyhydroxy-alpha-cyanocinnamate (1 micromol/l) failed to reduce the BK-induced dilation. However, the H(2)O(2) scavenger catalase (400 U/ml) abolished the response (from 54 +/- 11 to 0 +/- 2 microm; P < 0.01). The ATP-dependent K(+) (K(ATP)) channel inhibitor glibenclamide (10 micromol/l) had a similar effect as well (from 54 +/- 11 to 16 +/- 5 microm; P < 0.05). Coapplication of the Ca(2+)-dependent K(+) channel inhibitors charybdotoxin (0.1 micromol/l) and apamin (0.5 micromol/l) failed to reduce the response. We conclude that H(2)O(2) mediates the non-nitric oxide-, non-prostanoid-dependent vasorelaxation to BK in the piglet pial vasculature. The response is mediated via BK(2) receptors and the opening of K(ATP) channels.


Subject(s)
Arteries/drug effects , Biological Factors/metabolism , Bradykinin/administration & dosage , Hydrogen Peroxide/pharmacology , Pia Mater/blood supply , Administration, Topical , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Arteries/metabolism , Dose-Response Relationship, Drug , Enzyme Activators/pharmacology , Enzyme Inhibitors/pharmacology , Female , Indomethacin/pharmacology , Injections, Intravenous , Male , NG-Nitroarginine Methyl Ester/pharmacology , Phorbol 12,13-Dibutyrate/pharmacology , Potassium Channel Blockers/pharmacology , Potassium Channels/metabolism , Swine , Vasodilation/drug effects , Vasodilation/physiology , Vasodilator Agents/administration & dosage
6.
Am J Physiol Heart Circ Physiol ; 282(4): H1404-9, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11893577

ABSTRACT

N-methyl-D-aspartate (NMDA) elicits pial arteriolar dilation that has been associated with neuronal nitric oxide (NO) production. However, endothelial factors or glial P-450 epoxygenase products may play a role. We tested whether NMDA-induced pial vasodilation 1) primarily involves NO diffusion from the parenchyma to the surface arterioles, 2) involves intact endothelial function, and 3) involves a miconazole-sensitive component. Arteriolar diameters were determined using closed cranial window-intravital microscopy in anesthetized piglets. NMDA (10-100 microM) elicited virtually identical dose-dependent dilations in paired arterioles (r = 0.94, n = 15). However, NMDA- but not bradykinin (BK)-induced dilations of arteriolar sections over large veins were reduced by 31 +/- 1% (means +/- SE, P < 0.05, n = 4) compared with adjacent sections on the cortical surface. Also, 100 microM NMDA increased cerebrospinal fluid levels of NO metabolites from 3.7 +/- 1.0 to 5.3 +/- 1.2 microM (P < 0.05, n = 6). Endothelial stunning by intracarotid injection of phorbol 12,13-dibutyrate did not affect NMDA-induced vasodilation but attenuated vascular responses to hypercapnia and BK by approximately 70% (n = 7). Finally, miconazole (n = 6, 20 microM) pretreatment and coapplication with NMDA did not alter vascular responses to NMDA. In conclusion, NMDA appears to dilate pial arterioles exclusively through release and diffusion of NO from neurons to the pial surface in piglets.


Subject(s)
Arterioles/physiology , Dura Mater/blood supply , Endothelium, Vascular/physiology , N-Methylaspartate/pharmacology , Nitric Oxide/physiology , Pia Mater/blood supply , Receptors, N-Methyl-D-Aspartate/physiology , Vasodilation/physiology , Animals , Animals, Newborn , Arterioles/cytology , Arterioles/drug effects , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Female , Male , Miconazole/pharmacology , Microscopy , Receptors, N-Methyl-D-Aspartate/drug effects , Swine , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...